Case Study: Initial Public Offering of Foreign Medical Diagnostic Company

Case Study: Initial Public Offering of a Clinical Stage Biotech

Whitepaper: To IPO, or not to IPO, that is the question

This paper explores the current regulatory environment, market trends, the preparation necessary to ensure readiness, as well as the transition and long-term effects of becoming a public company.

More

IPOs and the “Cheap Stock” Issue

Despite the recent market volatility, the 2015 equity market continues to support initial public offerings (“IPOs”).

More